MECHANISMS OF POLYTOPIC PROTEIN BIOGENESIS IN THE ER

内质网中多位蛋白生物发生机制

基本信息

  • 批准号:
    6019102
  • 负责人:
  • 金额:
    $ 23.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-08-01 至 2001-05-31
  • 项目状态:
    已结题

项目摘要

Biogenesis and assembly of eukaryotic multispanning integral membrane proteins is proposed to occur cotranslationally through the action of independent topogenic sequences which direct sequential translocation initiation, termination and membrane integration events at the ER membrane. Recent studies, however, have demonstrated new complexities in this biosynthetic pathway. For a subset of native multispanning proteins, cooperative interactions rather than sequential independent activities may transiently delay integration of the chain into the membrane until synthesis of multiple transmembrane segments has been completed. Remarkably, novel topogenic determinants have also been identified which direct biogenesis of multiple topologic isoforms from a single polypeptide chain. These findings have important implications for the structure and function of diverse membrane proteins and require a detailed reexamination of the molecular mechanisms involved in their assembly. To better understand different biogenesis pathways utilized by polytopic proteins, the proposed studies will: i) identify the nature of information encoded within sequence determinants in the nascent chain which direct different translocation and membrane integration events, ii) determine how this information is interpreted by translocation machinery and/or chaperones at the ER membrane to effect different assembly mechanisms and, iii) investigate the effects of different biogenesis pathways on final protein structure and function. Three different proteins, human MDR1, CHIP28, AND MIWC, each of which demonstrate different biogenesis pathways will be studied using cell-free translation systems, Xenopus oocytes and cultured mammalian cells. Topogenic sequence determinants will be characterized in defined protein chimeras and in native contexts to identify key information responsible for translocation specificity and membrane integration. Interactions between these determinants and components of the translocation machinery will be identified by crosslinking ER proteins to nascent chains at specific stages of biogenesis. Finally, the role of different topological isoforms in protein maturation and function will be investigated. These studies will accomplish three important goals. First, they systematically define determinants which direct distinct events of topological maturation. Second, they identify translocation machinery and cellular chaperones through which these determinants act. Third, they correlate different biogenesis mechanisms with requirements for protein function. This work will provide a detailed understanding of cellular mechanisms which regulate polytopic protein assembly and allow further investigation into how these pathways might be disrupted in acquired or inherited human diseases.
真核生物多跨整体膜的形成与组装

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM R SKACH其他文献

WILLIAM R SKACH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM R SKACH', 18)}}的其他基金

Biogenesis and Molecular Pathogenesis of CFTR
CFTR 的生物发生和分子发病机制
  • 批准号:
    7992505
  • 财政年份:
    2010
  • 资助金额:
    $ 23.81万
  • 项目类别:
BIOGENESIS AND MOLECULAR PATHOGENESIS OF CFTR
CFTR 的生物发生和分子发病机制
  • 批准号:
    2874278
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Mechanisms of Polytopic Protein Biogenesis in the ER
内质网中多位蛋白生物合成的机制
  • 批准号:
    6985675
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Biogenesis and Molecular Pathogenesis of CFTR
CFTR 的生物发生和分子发病机制
  • 批准号:
    8039896
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Mechanisms of Polytopic Protein Biogenesis in the ER
内质网中多位蛋白生物合成的机制
  • 批准号:
    6636152
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Mechanisms of Polytopic Protein Biogenesis in the ER
内质网多位蛋白生物发生机制
  • 批准号:
    6331896
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Biogenesis and Molecular Pathogenesis of CFTR
CFTR 的生物发生和分子发病机制
  • 批准号:
    7781290
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Biogenesis and Molecular Pathogenesis of CFTR
CFTR 的生物发生和分子发病机制
  • 批准号:
    8246410
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
Mechanisms of Polytopic Protein Biogenesis in the ER
内质网中多位蛋白生物合成的机制
  • 批准号:
    6751215
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:
MECHANISMS OF POLYTOPIC PROTEIN BIOGENESIS IN THE ER
内质网中多位蛋白生物发生机制
  • 批准号:
    2192820
  • 财政年份:
    1996
  • 资助金额:
    $ 23.81万
  • 项目类别:

相似国自然基金

P-glycoprotein与Rack1和Src相互作用并促进耐药乳腺癌细胞侵袭转移的分子机制研究
  • 批准号:
    81472474
  • 批准年份:
    2014
  • 资助金额:
    85.0 万元
  • 项目类别:
    面上项目

相似海外基金

Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
  • 批准号:
    10568723
  • 财政年份:
    2023
  • 资助金额:
    $ 23.81万
  • 项目类别:
Physiological function of P-glycoprotein in sanctuary tissue barriers in teleosts
P-糖蛋白在硬骨鱼保护区组织屏障中的生理功能
  • 批准号:
    RGPIN-2020-04905
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
    Discovery Grants Program - Individual
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Undergraduate Summer Research
P-糖蛋白药物相互作用的研究 - 本科生暑期研究行政补充
  • 批准号:
    10810072
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
Bacterial targeting of the P-glycoprotein/endocannabinoid axis for reducing intestinal inflammation in ulcerative colitis
细菌靶向 P-糖蛋白/内源性大麻素轴以减少溃疡性结肠炎的肠道炎症
  • 批准号:
    10537517
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
Studies of P-glycoprotein drug interactions
P-糖蛋白药物相互作用的研究
  • 批准号:
    10661486
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
药物、核苷酸和脂质与 P-糖蛋白的相互作用
  • 批准号:
    10672242
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
Mechanisms of suicide attempts by loss of P-glycoprotein function in the blood-brain barrier
血脑屏障中 P-糖蛋白功能丧失导致自杀未遂的机制
  • 批准号:
    22K06774
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies of P-glycoprotein drug interactions
P-糖蛋白药物相互作用的研究
  • 批准号:
    10366914
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Equipment Purchase
P-糖蛋白药物相互作用研究-设备采购行政补充
  • 批准号:
    10795338
  • 财政年份:
    2022
  • 资助金额:
    $ 23.81万
  • 项目类别:
Organic Anion Transporting Polypeptide (OATP), P-glycoprotein (P-gp), and Breast Cancer Resistance Protein (BCRP) transporters modulate tamoxifen response during breast cancer therapy
有机阴离子转运多肽 (OATP)、P-糖蛋白 (P-gp) 和乳腺癌抗性蛋白 (BCRP) 转运蛋白在乳腺癌治疗期间调节他莫昔芬反应
  • 批准号:
    452037
  • 财政年份:
    2021
  • 资助金额:
    $ 23.81万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了